APA (7th ed.) Citation

Ensminger, S., Fujita, B., Aboud, A., Paitazoglou, C., Eitel, I., Jurczyk, D., . . . Zimmermann, W. (2024). Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-DZHK20): Trial Design and Experience at UKSH Lübeck. Thoracic & Cardiovascular Surgeon, 72, S1. https://doi.org/10.1055/s-0044-1780639

Chicago Style (17th ed.) Citation

Ensminger, S., et al. "Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-DZHK20): Trial Design and Experience at UKSH Lübeck." Thoracic & Cardiovascular Surgeon 72 (2024): S1. https://doi.org/10.1055/s-0044-1780639.

MLA (9th ed.) Citation

Ensminger, S., et al. "Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure (BioVAT-DZHK20): Trial Design and Experience at UKSH Lübeck." Thoracic & Cardiovascular Surgeon, vol. 72, 2024, p. S1, https://doi.org/10.1055/s-0044-1780639.